Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology

Philips advances minimally invasive therapy procedures in prostate cancer care with FDA 510(k) clearance for image-guided navigation technology

July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands –...

Philips UroNav System for Prostate Cancer Treatment Cleared by FDA - Endovascular Today

August 5, 2025—Royal Philips recently announced FDA 510(k) clearance of the latest version of the company’s UroNav system for image-guided navigation in prostate cancer care treatment. The system includes a new advanced annotation workflow that supports clinicians during focal therapy procedures to help deliver precise minimally invasive care, stated the company. According to Philips, UroNav is an image fusion system that integrates preprocedura…

FDA clears Philips’ image-guided navigation system for prostate cancer

The FDA has granted 510(k) clearance for Philips’ latest UroNav version, an advancement in image-guided navigation for prostate cancer care.The post FDA clears Philips’ image-guided navigation system for prostate cancer appeared first on Medical Device Network.

FDA clears image-guided navigation platform for focal therapy in prostate cancer

The new advanced annotation workflow on the UroNav System is designed to work in tandem with DynaCAD Urology to support focal therapy planning.

FDA Clears Updated MRI/Ultrasound Fusion System for Use in Focal Therapy of Prostate Cancer

Advanced annotation with the updated UroNav MRI/ultrasound fusion platform may facilitate enhanced precision and efficiency with focal therapies for prostate cancer.